Pliant Therapeutics, Inc. (PLRX) stock
PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.66−0.03 (-4.76%)
Close on Nov 17, 2026Market cap $40.88MP/E –Yield 0.00%
Pliant Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pliant Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0, down 100.0% year over year. For fiscal 2025 it was $0. The highest annual figure on record is $57.05M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | – |
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2023 | Dec 31, 2023 | $1.58M | -83.7% |
| FY2022 | Dec 31, 2022 | $9.69M | +27.9% |
| FY2021 | Dec 31, 2021 | $7.57M | -81.9% |
| FY2020 | Dec 31, 2020 | $41.82M | -26.7% |
| FY2019 | Dec 31, 2019 | $57.05M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | -100.0% |
| Q1 FY2024 | Mar 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $248.00K | -95.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.33M | +6.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.97M | -1.7% |
| Q3 FY2022 | Sep 30, 2022 | $1.48M | -8.0% |
| Q2 FY2022 | Jun 30, 2022 | $4.99M | +178.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.25M | -42.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.00M | -55.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.61M | -66.6% |
| Q2 FY2021 | Jun 30, 2021 | $1.79M | -50.3% |
| Q1 FY2021 | Mar 31, 2021 | $2.17M | -92.5% |
| Q4 FY2020 | Dec 31, 2020 | $4.47M | – |
| Q3 FY2020 | Sep 30, 2020 | $4.81M | – |
| Q2 FY2020 | Jun 30, 2020 | $3.60M | – |
| Q1 FY2020 | Mar 31, 2020 | $28.94M | – |
See a number that looks wrong?